Transaction | Address | Amount |
---|---|---|
0x7425...73c6d4
|
0x4634...eb9758
|
-
0.00069176221065 ETH
·
1.24 USD
|
0x7425...73c6d4
|
0xdafe...c98bc5
|
+
0.00069176221065 ETH
·
1.24 USD
|
0x7425...73c6d4
|
0x4634...eb9758
|
-
0.495000000000002 ETH
·
890.94 USD
|
0x7425...73c6d4
|
0x7551...c4301d
|
+
0.495000000000002 ETH
·
890.94 USD
|
0xbe00...395457
|
0x4634...eb9758
|
-
0.003941678985083421 ETH
·
7.09 USD
|
0xbe00...395457
|
the-void |
+
0.003941678985083421 ETH
·
7.09 USD
|
0xbe00...395457
|
0x4634...eb9758
|
-
0.00208217131299885 ETH
·
3.74 USD
|
0xbe00...395457
|
0xdafe...c98bc5
|
+
0.00208217131299885 ETH
·
3.74 USD
|
0xbe00...395457
|
0x4634...eb9758
|
-
0 ETH
·
0.00 USD
|
0xbe00...395457
|
0xdac1...831ec7
|
+
0 ETH
·
0.00 USD
|
BitMine opts for a $1 billion share repurchase plan, prioritizing buybacks over increasing its Ethereum holdings, as its stock trades below net asset value.
Abraxas Capital faces $100M in unrealized losses on $800M crypto shorts amidst a bullish market.
180 Life Sciences pivots to crypto with a $425 million investment in Ethereum, aiming to become "ETHZilla" and create the largest corporate ETH treasury.